# Princess Máxima Center for Pediatric Oncology

Source: https://onco.cc/institutions/princess-maxima/  
OnCo record `princess-maxima` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The national children's cancer centre of the Netherlands, which concentrates all Dutch paediatric oncology care and research on one Utrecht campus.

## Summary

Opened in 2018, the Princess Máxima Center brought together paediatric oncology from the Dutch university hospitals into a single specialised hospital and research institute next to UMC Utrecht and the Wilhelmina Children's Hospital. Every child is offered whole-genome and transcriptome sequencing at diagnosis, and research groups led by figures such as Jarno Drost, Monique den Boer and Michel Zwaan develop tumour organoids, leukaemia genomics and early-phase drug trials through the ITCC European consortium. Alexander Eggermont serves as chief scientific officer. The centre treats leukaemias, brain tumours, neuroblastoma, sarcomas and renal tumours, offers CAR-T and transplantation, and runs one of Europe's largest paediatric cancer survivorship programmes.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Prinses Máxima Centrum; Máxima
- City: Utrecht, NL
- Type: cancer-center
- Website: https://www.prinsesmaximacentrum.nl/en

## Sources

- Homepage: https://www.prinsesmaximacentrum.nl/en
- Research: https://research.prinsesmaximacentrum.nl

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/), [Neuroblastoma (paediatric)](https://onco.cc/cancers/neuroblastoma/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/), [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [Patient-derived organoids](https://onco.cc/technologies/organoids/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/), [Whole-exome & whole-genome sequencing](https://onco.cc/technologies/wes-wgs/)
- companies: [EORTC](https://onco.cc/companies/curie-nki-eortc/), [Innovative Therapies for Children with Cancer (ITCC)](https://onco.cc/companies/itcc/)
- institutions: [UMC Utrecht Cancer Center](https://onco.cc/institutions/umc-utrecht/)
- people: [Alexander Eggermont](https://onco.cc/people/alexander-eggermont/), [Inge M. van der Sluis](https://onco.cc/people/inge-van-der-sluis/), [René Medema](https://onco.cc/people/rene-medema/), [Rob Pieters](https://onco.cc/people/rob-pieters/)
- bottlenecks: [Rare and paediatric cancers without markets](https://onco.cc/bottlenecks/b-rare-cancers/), [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/)

---
JSON: https://onco.cc/api/v1/entities/princess-maxima.json